{"id":"NCT00525798","sponsor":"Nordic Bioscience A/S","briefTitle":"A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D","officialTitle":"A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2011-08","completion":"2011-11","firstPosted":"2007-09-06","resultsPosted":"2012-10-18","lastUpdate":"2012-10-29"},"enrollment":4665,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoporosis"],"interventions":[{"type":"DRUG","name":"SMC021 Oral calcitonin","otherNames":[]},{"type":"DRUG","name":"SMC021 Placebo","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"SMC021- Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoporosis","primaryOutcome":{"measure":"Number of Patients With New Vertebral Fractures","timeFrame":"From baseline to month 36","effectByArm":[{"arm":"SMC021","deltaMin":94,"sd":null},{"arm":"Placebo","deltaMin":99,"sd":null}],"pValues":[]},"eligibility":{"minAge":"55 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":16,"countries":["United States","Brazil","China","Czechia","Denmark","Estonia","France","Hong Kong","Italy","Lithuania","Poland","Romania"]},"refs":{"pmids":["20932224"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":340,"n":2334},"commonTop":["Back Pain","Arthralgia","Nasopharyngitis","Hypertension","Nausea"]}}